3
Views
38
CrossRef citations to date
0
Altmetric
Gene Expression

Presence of Negative and Positive cis-Acting RNA Splicing Elements within and Flanking the First tat Coding Exon of Human Immunodeficiency Virus Type 1

, , &
Pages 3960-3970 | Received 04 Jan 1994, Accepted 17 Mar 1994, Published online: 30 Mar 2023

REFERENCES

  • Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and non-human cells transfected with an infectious molecular clone. J. Virol. 59: 284–291.
  • Arrigo, S., and K. Beemon. 1988. Regulation of Rous sarcoma virus RNA splicing and stability. Mol. Cell. Biol. 8: 4858–4867.
  • Berberich, S. L., and C. M. Stoltzfus. 1991. Analysis of spliced and unspliced Rous sarcoma virus RNAs early and late after infection of chicken embryo fibroblasts: effect of cell culture conditions. Virology 182: 135–144.
  • Berberich, S. L., and C. M. Stoltzfus. 1991. Mutations in the regions of the Rous sarcoma virus 3′ splice sites: implications for regulation of alternative splicing. J. Virol. 65: 2640–2646.
  • Chang, D. D., and P. A. Sharp. 1989. Regulation by HIV Rev depends upon recognition of splice sites. Cell 59: 789–795.
  • Chang, L. J. Submitted for publication.
  • Chang, L. J. Unpublished data.
  • Cooper, T. A. 1992. In vitro splicing of cardiac troponin T precursors. J. Biol. Chem. 267: 5330–5338.
  • Cooper, T. A., and C. P. Ordahl. 1989. Nucleotide substitutions within the cardiac troponin T alternative exon disrupt pre-mRNA alternative splicing. Nucleic Acids Res. 17: 7905–7931.
  • Cote, G. J., I. N. Nguyen, S. M. Berget, and R. F. Gagel. 1990. Calcitonin exon sequences influence alternative RNA processing. Mol. Endocrinol. 4: 1744–1749.
  • Cote, G. J., D. T. Stolow, S. Peleg, S. M. Berget, and R. F. Gagel. 1992. Identification of exon sequences and an exon binding protein involved in alternative RNA splicing of calcitonin/CGRP. Nucleic Acids Res. 20: 2361–2366.
  • Cullen, B. R. 1991. Regulation of human immunodeficiency virus replication. Annu. Rev. Microbiol. 45: 219–250.
  • Daly, T. J., K. S. Cook, G. S. Gray, T. E. Maione, and J. R. Rusche. 1989. Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro. Nature (London) 342: 816–819.
  • Dietsch, J., and C. M. Stoltzfus. Unpublished data.
  • Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11: 1475–1489.
  • Domenjoud, L., H. Gallinaro, L. Kister, S. Meyer, and M. Jacob. 1991. Identification of a specific exon sequence that is a major determinant in the selection between a natural and a cryptic 5′ splice site. Mol. Cell. Biol. 11: 4581–4590.
  • Emerman, M., R. Vazeus, and K. Peden. 1989. The rev gene product of the human immunodeficiency virus affects envelope-specific RNA localization. Cell 57: 1155–1165.
  • Felber, B. K., C. M. Drysdale, and G. N. Pavlakis. 1990. Feedback regulation of human immunodeficiency virus type 1 expression by the Rev protein. J. Virol. 64: 3734–3741.
  • Felber, B. K., M. Hadzopoulou-Cladaras, C. Cladaras, T. Cope-land, and G. N. Pavlakis. 1989. Rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc. Natl. Acad. Sci. USA 86: 1495–1499.
  • Fu, X.-D. 1993. Specific commitment of different pre-mRNAs to splicing by single SR proteins. Nature (London) 365: 82–85.
  • Fu, X.-D., R. A. Katz, A. M. Skalka, and T. Maniatis. 1991. The role of branchpoint and 3′-exon sequences in the control of balanced splicing of avian retrovirus RNA. Genes Dev. 5: 211–220.
  • Garrett, E. D., L. S. Tiley, and B. R. Cullen. 1991. Rev activates expression of the human immunodeficiency virus type 1 vif and vpr gene products. J. Virol. 65: 1653–1657.
  • Grabowski, P. J., F. H. Nasim, H. Kuo, and R. Burch. 1991. Combinatorial splicing of exon pairs by two-site binding of U1 small nuclear ribonucleoprotein particle. Mol. Cell. Biol. 11: 5919–5928.
  • Graham, F. J., and A. J. Van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52: 456–460.
  • Green, M. R. 1991. Biochemical mechanisms of constitutive and regulated pre-mRNA splicing. Annu. Rev. Cell Biol. 7: 559–599.
  • Guatelli, J. C., T. R. Gingeras, and D. D. Richman. 1990. Alternative splice acceptor utilization during human immunodeficiency virus type 1 infection of cultured cells. J. Virol. 64: 4093–4098.
  • Hadzopoulou-Cladaras, M., B. K. Felber, C. Cladaras, A. Athan-assopoulos, A. Tse, and G. Pavlakis. 1989. The ref (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region. J. Virol. 63: 1265–1274.
  • Hammarskjold, M.-L., J. Heimer, B. Hammarskjold, I. Sangwan, L. Albert, and D. Rekosh. 1989. Regulation of human immunodeficiency virus env expression by the rev gene product. J. Virol. 63: 1959–1966.
  • Hampson, R. K., L. L. Follette, and F. M. Rottman. 1989. Alternative processing of bovine growth hormone mRNA is influenced by downstream exon sequences. Mol. Cell. Biol. 9: 1604–1610.
  • Heaphy, S., C. Dingwall, I. Ernberg, M. Gait, S. M. Green, J. Kara, A. D. Lowe, M. Singh, and M. A. Skinner. 1990. HIV-1 regulator of virion expression (Rev) protein binds to an RNA stem-loop structure located within the Rev response element region. Cell 60: 685–693.
  • Helfman, D. M., W. M. Ricci, and L. A. Finn. 1988. Alternative splicing of tropomyosin pre-mRNAs in vitro and in vivo. Genes Dev. 2: 1627–1638.
  • Hoffman, B. E., and P. J. Grabowski. 1992. Ul snRNP targets an essential splicing factor U2AF65, to the 3′ splice site by a network of interactions spanning the exon. Genes Dev. 6: 2554–2568.
  • Ivey-Hoyle, M., and M. Rosenberg. 1990. Rev-dependent expression of human immunodeficiency virus type 1 gpl62 in Drosophila melanogaster cells. Mol. Cell. Biol. 10: 6152–6159.
  • Katz, R. A., and A. M. Skalka. 1990. Control of retroviral splicing through maintenance of suboptimal splicing signals. Mol. Cell. Biol. 10: 696–704.
  • Krainer, A. R., G. C. Conway, and D. Kozak. 1990. Purification and characterization of pre-mRNA splicing factor SF2 from HeLa cells. Genes Dev. 4: 1158–1171.
  • Krainer, A. R., T. Maniatis, B. Ruskin, and M. R. Green. 1984. Normal and mutant human beta-globin pre-mRNAs are faithfully and efficiently spliced in vitro. Cell 36: 993–1005.
  • Libri, D., M. Goux-Pelletan, E. Brody, and M. Y. Fiszman. 1990. Exon as well as intron sequences are cis-regulating elements for the mutually exclusive alternative splicing of the β tropomyosin gene. Mol. Cell. Biol. 10: 5036–5046.
  • Libri, D., A. Piseri, and M. Y. Fiszman. 1991. Tissue-specific splicing in vivo of the beta-tropomyosin gene: dependence on an RNA secondary structure. Science 252: 1842–1845.
  • Ligtenberg, M. J. L., M. Gennissen, H. L. Vos, and J. Hilkens. 1990. A single nucleotide polymorphism in an exon dictates allele dependent differential splicing of episialin mRNA. Nucleic Acids Res. 19: 297–301.
  • Maldarelli, F., M. A. Martin, and K. Strebel. 1991. Identification of posttranscriptionally active inhibitory sequences in human immunodeficiency virus type 1 RNA: novel level of gene regulation. J. Virol. 65: 5732–5743.
  • Malim, M. H., and B. R. Cullen. 1993. Rev and the fate of pre-mRNA in the nucleus: implications for the regulation of RNA processing in eukaryotes. Mol. Cell. Biol. 13: 6180–6189.
  • Malim, M. H., J. Hauber, S.-Y. Le, J. V. Maizel, and B. R. Cullen. 1989. The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature (London) 338: 254–257.
  • Mardon, H. J., G. Sebastio, and F. E. Baralle. 1987. A role for exon sequences in alternative splicing of the human fibronectin gene. Nucleic Acids Res. 15: 7725–7733.
  • McNally, M., and K. Beemon. Personal communication.
  • Melton, D. A., P. A. Krieg, M. R. Rebagliati, T. Maniatis, K. Zinn, and M. R. Green. 1984. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res. 12: 7035–7056.
  • Meyers, G., B. Korber, J. A. Berzofsky, R. F. Smith, and G. N. Pavlakis. 1992. Human retroviruses and AIDS: a compilation and analysis of nucleic acid and amino acid sequences. Los Alamos National Laboratory, Los Alamos, N. Mex.
  • Muesing, M. A., D. H. Smith, C. D. Cabradilla, C. V. Benton, L. A. Lasky, and D. J. Capon. 1985. Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus. Nature (London) 313: 450–458.
  • Nagoshi, R. N., and B. S. Baker. 1990. Regulation of sex-specific RNA splicing at the Drosophila doublesex gene: cis-acting mutations in exon sequence alter sex-specific RNA splicing patterns. Genes Dev. 4: 89–97.
  • Olsen, H. S., A. W. Cochrane, and C. Rosen. 1992. Interaction of cellular factors with intragenic cis-acting repressive sequences within the HIV genome. Virology 191: 709–715.
  • Olsen, H. S., P. Nelbock, A. W. Cochrane, and C. A. Rosen. 1990. Secondary structure is the major determinant for interaction of HIV Rev protein with RNA. Science 247: 845–848.
  • Peterlin, B. M., P. A. Luciw, P. J. Barr, and M. D. Walker. 1986. Elevated levels of mRNA can account for the transactivation of human immunodeficiency virus (HIV). Proc. Natl. Acad. Sci. USA 83: 9734–9738.
  • Purcell, D. F. J., and M. A. Martin. 1993. Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication and infectivity. J. Virol. 67: 6365–6378.
  • Reed, R., and T. Maniatis. 1986. A role for exon sequences and splice-site proximity in splice-site selection. Cell 46: 681–690.
  • Robberson, B. L., G. J. Cote, and S. M. Berget. 1990. Exon definition may facilitate splice site selection in RNAs with multiple exons. Mol. Cell. Biol. 10: 84–94.
  • Robert-Guroflf, M., M. Popovic, S. Gartner, P. Markham, R. C. Gallo, and M. S. Reitz. 1990. Structure and expression of tat-, rev-, and /-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages. J. Virol. 64: 3391–3398.
  • Rodcigno, R. F., M. Weiner, and M. A. Garcia-Blanco. 1993. A mutational analysis of the polypyrimidine tracts of introns: effects of sequence differences in pyrimidine tracts on splicing. J. Biol. Chem. 268: 11222–11229.
  • Roesser, J. R., K. Liittschwager, and S. E. Leff. 1993. Regulation of tissue-specific splicing of the calcitonin/calcitonin gene-related peptide gene by RNA-binding proteins. J. Biol. Chem. 268: 8366–8375.
  • Rosen, C. A., E. Terwilliger, A. Dayton, J. G. Sodroski, and W. A. Haseltine. 1988. Intragenic as-acting art gene-responsive sequences of the human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 85: 2071–2075.
  • Ruskin, B., A. R. Krainer, T. Maniatis, and M. R. Green. 1984. Excision of an intact intron as a novel lariat structure during pre-mRNA splicing in vitro. Cell 38: 317–331.
  • Sadaie, M. R., J. Rappaport, T. Benter, S. F. Josephs, R. Willis, and F. Wong-Staal. 1988. Missense mutations in an infectious human immunodeficiency viral genome: functional mapping of tat and identification of the rev splice acceptor. Proc. Natl. Acad. Sci. USA 85: 9224–9228.
  • Schwartz, D. E., R. Tizard, and W. Gilbert. 1983. Nucleotide sequence of Rous sarcoma virus. Cell 32: 853–869.
  • Schwartz, S., B. K. Felber, D. M. Benko, E.-M. Fenyo, and G. N. Pavlakis. 1990. Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. J. Virol. 64: 2519–2529.
  • Schwartz, S., B. K. Felber, E.-M. Fenyo, and G. N. Pavlakis. 1990. Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs. J. Virol. 64: 5448–5456.
  • Schwartz, S., B. K. Felber, and G. N. Pavlakis. 1992. Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein. J. Virol. 66: 150–159.
  • Steingrimsdottir, H., G. Rowley, G. Dorado, J. Cole, and A. R. Lehman. 1992. Mutations which alter splicing in human hypoxan-thine-guanine phosphoribosyltransferase gene. Nucleic Acids Res. 20: 1201–1208.
  • Stoltzfus, C. M. Unpublished data.
  • Stoltzfus, C. M., and S. J. Fogarty. 1989. Multiple regions in the Rous sarcoma virus src gene intron act in cis to affect accumulation of unspliced RNA. J. Virol. 63: 1669–1676.
  • Stoltzfus, C. M., S. K. Lorenzen, and S. L. Berberich. 1987. Noncoding region between the env and src genes of Rous sarcoma virus influences splicing efficiency at the src gene 3′ splice site. J. Virol. 61: 177–184.
  • Streuli, M., L. R. Hall, Y. Saga, S. F. Schlossman, and H. Saito. 1987. Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigens. J. Exp. Med. 166: 1548–1566.
  • Strohman, R., P. Moss, J. Micou-Eastwood, D. Spector, A. Przy-byla, and B. Peterson. 1977. Messenger RNA for myosin polypeptides: isolation from single myogenic cell cultures. Cell 10: 265–273.
  • Sun, Q., R. K. Hampson, and F. M. Rottman. 1993. In vitro analysis of bovine growth hormone pre-mRNA alternative splicing: involvement of exon sequences and trans-acting factors. J. Biol. Chem. 268: 15659–15666.
  • Tian, M., and T. Maniatis. 1993. A splicing enhancer complex controls alternative splicing of doublesex pre-mRNA. Cell 74: 105–114.
  • Tsai, A. Y., M. Streuli, and H. Saito. 1989. Integrity of the exon 6 sequence is essential for tissue-specific alternative splicing of human leukocyte common antigen pre-mRNA. Mol. Cell. Biol. 9: 4550–4555.
  • Wakamatsu, N., H. Kobayashi, T. Miyatake, and S. Tsuji. 1992. A novel exon mutation in the human beta-hexosaminidase beta subunit gene affects 3′ splice site selection. J. Biol. Chem. 267: 2406–2413.
  • Watakabe, A., H. Inoue, H. Sakamoto, and Y. Shimura. 1989. A secondary structure at the 3′ splice site affects the in vitro splicing reaction to mouse immunoglobulin mu chain pre-mRNAs. Nucleic Acids Res. 17: 8159–8169.
  • Watakabe, A., K. Tanaka, and Y. Shimura. 1993. The role of exon sequences in splice site selection. Genes Dev. 7: 407–418.
  • Xu, R., J. Teng, and T. A. Cooper. 1993. The cardiac troponin T alternative exon contains a novel purine-rich positive splicing element. Mol. Cell. Biol. 13: 3660–3674.
  • Yeakley, J. M., F. Hedjran, J.-P. Morfin, N. Merillat, M. G. Rosenfeld, and R. B. Emeson. 1993. Control of calcitonin/calcitonin gene-related peptide pre-mRNA processing by constitutive intron and exon elements. Mol. Cell. Biol. 13: 5999–6011.
  • Zapp, M. L., and M. R. Green. 1989. Sequence-specific RNA binding by the HIV-1 Rev protein. Nature (London) 342: 714–716.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.